Neidio i'r cynnwys
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Uwch
  • Duchenne Muscular Dystrophy: M...
  • Dyfynnu hwn
  • Anfonwch hwn fel neges destun
  • E-bostio hwn
  • Argraffu
  • Allforio Cofnod
    • Allforio i RefWorks
    • Allforio i EndNoteWeb
    • Allforio i EndNote
  • Permanent link
Duchenne Muscular Dystrophy: Modern Approaches in Patient Management

Duchenne Muscular Dystrophy: Modern Approaches in Patient Management

Duchenne muscular dystrophy is one of the most common forms of childhood muscular dystrophies. Its incidence is 1 in 3.5–6 thousand newborn boys according to various sources. The disease is caused by the mutation in the DMD gene coding the dystrophin protein, it leads to the dystrophin absence or ma...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Inga V. Anisimova, Svetlana B. Artemyeva, Elena D. Belousova, Nato D. Vashakmadze, Dmitriy V. Vlodavets, Tatiana A. Gremyakova, Olga S. Groznova, Valentina I. Guzeva, Elena V. Gusakova, Lyudmila M. Kuzenkova, Alexey L. Kurenkov, Sergey I. Kutsev, Svetlana V. Mikhaylova, Lyudmila P. Nazarenko, Sergey S. Nikitin, Artem Yu. Novikov, Tatiana V. Podkletnova, Elena V. Polevichenko, Alexander V. Polyakov, Gennady G. Prokopyev, Dmitry I. Rudenko, Svetlana A. Repina, Evgeniia V. Romanenko, Sergey O. Ryabykh, Gul’zhan E. Sakbaeva, Elena Yu. Sapego, Liliia R. Selimzyanova, Andrey A. Stepanov, Dmitry M. Subbotin, Vasiliy M. Suslov, Elena V. Tozliyan, Dmirty A. Feklistov, Nadezhda I. Shakhovskaya, Ekaterina V. Shreder
Fformat: Erthygl
Iaith:Russian
Cyhoeddwyd: Union of pediatricians of Russia 2023-11-01
Cyfres:Педиатрическая фармакология
Pynciau:
duchenne myodystrophy
hereditary diseases
cardiomyopathies
pathogenetic therapy
rehabilitation
children
Mynediad Ar-lein:https://www.pedpharma.ru/jour/article/view/2348
  • Daliadau
  • Disgrifiad
  • Eitemau Tebyg
  • Dangos Staff

Rhyngrwyd

https://www.pedpharma.ru/jour/article/view/2348

Eitemau Tebyg

  • Identification of patients with orfan pathology as a result of routine creatine phosphokinase level analysis. The experience of the Krasnoyarsk Territory
    gan: E. V. Shishkina
    Cyhoeddwyd: (2024-04-01)
  • CLINICAL CASE OF DUCHENNE MYODYSTROPHY
    gan: Elena Anatolyevna Tkachuk, et al.
    Cyhoeddwyd: (2023-06-01)
  • Adequate managment of patients with dystrophinopathies (muscular dystrophy Duchenne/Becker): objective scales and additional diagnostic methods
    gan: A. S. Nosko, et al.
    Cyhoeddwyd: (2015-02-01)
  • The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
    gan: T. A. Gremyakova, et al.
    Cyhoeddwyd: (2022-06-01)
  • THE ROLE OF SELENIUM PREPARATIONS AND VITAMIN E IN NUTRITIONAL MYODYSTROPHY (WHITE MUSCLE DISEASE) IN SHEEP
    gan: Stancu, A
    Cyhoeddwyd: (2017-06-01)

Opsiynau Chwilio

  • Hanes Chwilio
  • Chwiliad Uwch

Canfod Mwy

  • Pori'r Catalog
  • Pori yn ôl y Wyddor
  • Archwiliwch Sianeli
  • Cronfeydd y Cwrs
  • Eitemau Newydd

Angen Help?

  • Awgrymiadau Chwilio
  • Gofynnwch i Lyfrgellydd
  • Cwestiynau Cyffredin